Autonomix Medical, Inc.
THE WOODLANDS, TX · Founded 2014 · CIK 0001617867 · Medtech · Public
Real-time intra-procedural nerve mapping platform for guided transvascular denervation
autonomix.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $8.9M
- 4 Form D · Jun 2023
- 40 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 25 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142016201820202022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $3,800,000 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $675,000 | |
| Private capital raised | Form D · SEC | $2,399,990 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1999 | WIK DEVICES, LLC | — | — |
| 2000 | CAROLINA INSTRUMENTS, INC. | — | — |
| 2001 | FREYYA, INC. | — | — |
| 2002 | Autonomix Medical, Inc. | — | $8.9M |
| 2003 | Newmark Diagnostics LLC | — | — |
| 2004 | OVITZ CORPORATION | — | — |
| 2005 | JAVELIN BIOTECH INC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Jonathan FosterDirector
- Walter KlempDirector
- Matt LourieExecutive Officer
- Matthew LourieExecutive Officer
- Renee MasiDirector
- David RobinsDirector · Executive Officer
- Robert SchwartzDirector · Executive Officer
- Robert Van TasselExecutive Officer
Patents
- Systems And Methods For Regulating Organ And/or Tumor Growth Rates, Function, And/or Developmentgranted
- Devices, Systems, And Methods For Diagnosis And Treatment Of Overactive Bladderapplication
- Systems, Methods, And Devices For Monitoring And Treatment Of Tissues Within And/or Through A Lumen Wallapplication
- Devices, Systems, And Methods For Diagnosis And Treatment Of Overactive Bladdergranted
- Systems And Methods For Treating Cancer And/or Augmenting Organ Functionapplication
- Systems, Methods, And Devices For Monitoring And Treatment Of Tissues Within And/or Through A Lumen Wallgranted
- Medical Devices Configured For Therapeutic Electroporation Of Biologic Tissuesapplication
- Controlled And Precise Treatment Of Cardiac Tissuesapplication
- Ans Assessment Systems, Kits, And Methodsgranted
- Controlled Sympathectomy And Micro-ablation Systems And Methodsapplication
- Systems And Methods For Regulating Organ And/or Tumor Growth Rates, Function, And/or Developmentapplication
- Systems And Methods For Treating Cancer And/or Augmenting Organ Functiongranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.